BeStock  
Stocks › Biotechnology › PHAR

Pharming Group PHAR

US equityMarket cap rank #3287Biotechnology
$11.54 −$0.63 (-5.18%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $11.54 0.00%
Open$11.85
Prev close$12.17
Day range$11.30 – $11.97
Volume10.5K
Market cap$816.78M
P/E (TTM)35.0
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings38.2x
CheapRich

Above its usual level · 77th percentile, 5-year average -1.6x

#2386 of 2991 stocks by PE (1 = cheapest)

Price / book3.1x
CheapRich

Below its usual level · 38th percentile, 5-year average 3.4x

#3784 of 5328 stocks by PB (1 = cheapest)

Price / sales2.3x
CheapRich

Below its usual level · 27th percentile, 5-year average 2.9x

#2744 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-311x-40x230x501xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$15.61
Price vs. fair value-26.1%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.06 – 3.37 38% (cheaper than usual) #3784 of 5328 (1 = cheapest)
PE 38.18 31.52 -1.63 77% (pricier than usual) #2386 of 2991 (1 = cheapest)
PS 2.31 2.23 2.90 27% (cheaper than usual) #2744 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on PHAR.

Sign in to join the discussion.

Scroll to Top